Every finding on record at Southeastern Home Care, LLC

EMERGENCY PREPAREDNESS SURVEY At the time of the emergency preparedness survey completed on 05/18/23, Southeastern Home Care, LLC is in compliance with the provisions of 42 CFR Part 484.102, Conditions of Participation for Home Health Agencies.

Partial Extended Recertification Survey An entrance conference was conducted on 05/15/23 at 7:50 AM with the Manager of Clinical Services. An exit conference was conducted on 05/18/23 at 4:15 PM with administrative staff. The following deficiencies are based on the partial extended recertification survey completed on 05/18/23. Southeastern Home Care, LLC 367433, is not in compliance with the requirements at 42 CFR Part 484, Subpart B, C for Home Health Agencies.

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on observation, record review and patient and staff interview, the agency failed to review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy for three of seven patients with home visits (Patient #4, #5 and #6). The census was 146. Findings include: 1. Review of Patient #4’s medical record revealed the patient was admitted on 05/06/23. On 05/16/23 at 9:00 AM a home visit was made with Patient #4 and Staff G present. The patient was observed to be wearing oxygen. Review of the medication in the home taken by Patient #4 revealed prescriptions for Bumetanide (water pill) 0.5 milligrams (mg) to be taken every other day alone with 1.0 mg to be taken daily which was filled on 03/17/23; Vitamin K 100 micrograms (mcg) taken daily which was filled 03/17/23; and Stiolto-Respimat inhaler take two puffs daily. Review of the patient’s current medication profile for the certification period dated 05/06/23 through 07/04/23 revealed no evidence of Bumetanide, Vitamin K, Stiolto-Respimat inhaler or oxygen. Interview on 05/16/23 at 9:25 AM with Patient #4 revealed he had used the inhaler “for years” and had used the oxygen at three liters per nasal cannula for six years. Interview on 05/16/23 at 9:31 AM Staff G confirmed the medications and the oxygen were not listed on the current medication profile. 2. Review of Patient #5’s medical record revealed the patient was admitted on 05/04/23. On 05/16/23 at 10:30 AM a home visit was made with Patient #5 with Staff V present. Review of the medication in the home taken by Patient #5 revealed a bottle with the label Famotidine (antacid) 20 mg twice a day which was filled on 10/13/22. The patient’s current medication profile for the certification period dated 05/04/23 through 07/02/23 did not include this medication. Interview on 05/16/23 at 10:40 AM with Patient #5 revealed they had taken this for 15-20 years. Review of a medication label revealed a prescription for Magnesium Oxide 400 mg to be taken three times a day which was filled on 01/30/23. Review of the medication profile revealed an order for Magnesium Oxide 500 mg. Review of a medication label revealed a prescription for Hydralazine (for high blood pressure) 100 mg taken three times a day which was filled 05/08/23. The medication profile revealed an order for Hydralazine 100 mg taken twice a day. Review of a medication label revealed a prescription for Furosemide (diuretic) 20 mg to be taken twice a day. The medication profile revealed an order for Furosemide 20 mg to be taken daily. Interview on 05/16/23 at 10:54 AM with Staff V confirmed the medications taken in the home did not match the medication profile. Interview on 05/16/23 at 10:57 AM Patient #5 stated the staff on admission just looked at the medication list from the hospital and not the medication bottles. 3. Review of Patient #6’s medical record revealed the patient was admitted on 04/05/23. On 05/17/23 at 8:30 AM a home visit was made with Patient #6 with Staff S present. Review of medication in the home revealed prescriptions for Chlorthalidone (for blood pressure) 25 mg taken daily which was filled on 03/22/23; Lisinopril (for blood pressure) 20 mg to be taken twice a day which was filled on 01/23/23; and Vitamin D3 to be taken twice a day which was filled on 04/18/23. The patient’s medication profile for the certification period dated 04/05/23 through 06/03/23 did not include these medications. Interview on 05/17/23 at 9:04 AM with Patient #6 confirmed taking these medications. Interview on 05/17/23 at 9:06 AM Staff S confirmed these medications were not listed on the medication profile.